Item 8.01 Other Events
On
The Telavancin Observational Use Registry (TOUR™) was conducted to record population characteristics, prescription information, and real-world clinical outcomes of patients with Gram-positive infections treated with Vibativ. This publication assessed 151 patients in TOUR™ with endocarditis and/or bacteremia with a known or unknown primary source.
A copy of the press release is furnished as Exhibit 99.1 .
--------------------------------------------------------------------------------
© Edgar Online, source